Found 7 matching trials
Efficacy and Safety of Alirocumab in Patients With Hypercholesterolemia Not Adequately Controlled With Non-statin Lipid Modifying Therapy or the Lowest Strength of Statin PHASE3 Primary Objective:
To demonstrate the reduction of low-density lipoprotein...
Show More Location
Investigational Site Number 392028
Learn More & Join Trial
A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337 PHASE1 This study is a randomized, open-label, single oral dose, 2-way crossover c...
Show More Location
Multiple Locations
Learn More & Join Trial
Exploring the Impact of Nephropathy Formula No. 1 on Chronic Kidney Disease Patients EARLY_PHASE1 This study is a prospective randomized controlled trial, enrolling 70 patie...
Show More Location
The Third Affiliated Hospital of Zhejiang Chinese Medical University
Learn More & Join Trial
Atorvastatin Versus Ezetimibe and Fenofibrate as a Lipid-lowering Strategy N/A The primary aim of this study is to evaluate the efficacy and non-inferiori...
Show More Location
Vascular Disease Prevention and Research Centre, Hotel Dieu Hospital
Learn More & Join Trial
Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia N/A This study has the purpose to answer how the Lipoprotein(a) (Lp(a)) level i...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Prevention and Treatment Of Diabetes Complications With Gastric Surgery or Intensive Medicines NA The obesity and type 2 diabetes mellitus (T2DM) are among the most threaten...
Show More Location
Pontificia Universidad Católica de Chile
Learn More & Join Trial
A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337 PHASE1 A randomized, open-label, single oral dose, 2-way crossover clinical trial ...
Show More Location
Dong-A University Hospital
Learn More & Join Trial